Elbasvir/grazoprevir in children aged 3–18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study
暂无分享，去创建一个
M. Pawłowska | M. Jonas | Robert H. Squires | N. Alkhouri | B. Fischler | B. Haber | P. Rosenthal | W. Balistreri | R. Romero | S. Wirth | E. Majda-Stanisławska | W. Służewski | Lihong Du | L. Caro | A. Grandhi | T. Lang | D. Rosenbloom | R. Gonzalez-Peralta | Frauke Mutschler | Niviann Blondet | Patricia Castronuovo